Roughly one-quarter of men with this rare malignancy receive treatment outside of evidence-based recommendations for penile cancer, which puts their survival at risk.
Medscape Medical News
Original Article: Penis Cancer Treatment Decisions Often Misguided
NEXT ARTICLE